Tetraphase Pharmaceutical (NASDAQ:TTPH) Stock Quotes and News

2.850 -0.1 (-3.39%)

Data as of Aug 18, 2018

Prev. Close 2.95
Price Open 2.94
Volume 713,958
Day's Range 2.85 - 2.945
52 Wk Range 2.05 - 7.98
50 Day Moving Avg. 3.46
PE Ratio 0
Shares Outstanding 52.86M
Market Cap 150.65M

Trade TTPH stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Date	Research Firm	Action	Current	Target
3/29/18	Gabelli & Co.	Upgrades	HoldBuy
3/08/18	BMO Capital	Maintains	Market PerformMarket Perform	3.0
2/23/18	WBB Securities	Initiates Coverage On	Speculative Buy	6.0

The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings Shanthi RexalineFri, 03 Aug 2018 07:52:00 -0400
Tetraphase Pharmaceutical Q2 EPS $(0.18) Beats $(0.37) Estimate, Sales $11.6M Beat $2.19M Estimate Benzinga NewsdeskThu, 02 Aug 2018 17:03:00 -0400
Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates Shanthi RexalineWed, 01 Aug 2018 07:38:24 -0400
Tetraphase Pharmaceuticals Shares Up 12.3% Premarket After Co. Received Positive CHMP Opinion For Xerava As Treatment For Complicated Intra-Abdominal Infections; European Commission Is Expected To Make Final Approval Decision Within Next Three Months Benzinga NewsdeskFri, 27 Jul 2018 08:56:38 -0400
Tetraphase Pharmaceuticals Receives Positive CHMP Opinion For Xerava As Treatment For Complicated Intra-Abdominal Infections Benzinga_NewsdeskFri, 27 Jul 2018 08:33:59 -0400
40 Biggest Movers From Yesterday Lisa LevinFri, 15 Jun 2018 04:56:34 -0400
31 Stocks Moving In Thursday's Mid-Day Session Lisa LevinThu, 14 Jun 2018 12:26:05 -0400
23 Stocks Moving In Thursday's Pre-Market Session Lisa LevinThu, 14 Jun 2018 08:00:56 -0400
44 Biggest Movers From Yesterday Lisa LevinTue, 12 Jun 2018 04:49:30 -0400
32 Stocks Moving In Monday's Mid-Day Session Lisa LevinMon, 11 Jun 2018 12:25:13 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GLNCY, GLCNF, SBGL, GOGO, RMTI and TTPH Globe Newswire1 day ago
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tetraphase Pharmaceuticals, Inc. (TTPH) and Lead Plaintiff Deadline – September 25, 2018 Globe Newswire1 day ago
Robbins Geller Rudman & Dowd LLP Announces a Securities Case Has Been Filed on Behalf of Purchasers of Tetraphase Pharmaceuticals, Inc. Securities Business Wire2 days ago
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Tetraphase Pharmaceuticals, Inc. (TTPH) and Encourages Investors to Contact the Firm Globe Newswire2 days ago
SHAREHOLDER ALERT: RMTI TTPH FB HMNY GDS NLSN SBGI ORCL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Globe Newswire2 days ago
CLASS ACTION UPDATE for SBGL and TTPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire4 days ago
Robbins Arroyo LLP: Tetraphase Pharmaceuticals, Inc. (TTPH) Misled Shareholders According to a Recently Filed Class Action Business Wire4 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tetraphase Pharmaceuticals, Inc. - TTPH PRNewswire4 days ago
INVESTOR ALERT REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire4 days ago
SHAREHOLDER ALERT: MRCY GLNCY GLCNF MD FPI FIZZ SBGL ACAD ABBV TTPH RMTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Globe Newswire5 days ago
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tetraphase ... GuruFocus7 hours ago
Entasis Therapeutics files for $86.25M initial public offering Seeking Alpha10 hours ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GLNCY, ... GuruFocus1 day ago
SHAREHOLDER ALERT: RMTI TTPH FB HMNY GDS NLSN SBGI ORCL: The Law Offices of Vincent Wong ... GuruFocus2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tetraphase ... GuruFocusAug 10, 2018
SHAREHOLDER ALERT: UNM SBGL PCG ACAD RMTI TTPH FB: The Law Offices of Vincent Wong Reminds ... GuruFocusAug 10, 2018
SHAREHOLDER ALERT: MRCY COOL DB QCOM FPI GOGO TTPH: The Law Offices of Vincent Wong Reminds ... GuruFocusAug 05, 2018
Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/03/2018) Seeking AlphaAug 03, 2018
Tetraphase Pharmaceuticals beats by $0.19, beats on revenue Seeking AlphaAug 02, 2018
Your Daily Pharma Scoop: Tonix Halted, Endo Begins Shipment, Insys FDA-Rejected Seeking AlphaJul 30, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q2 2018	EST	Actual	Surprise
EPS:	-0.37	-0.18	0.19
Rev:	2.19M	11.58M	9.39M

Q3 2018	EST	Actual	Surprise
EPS:	Expected 2018-11-01
Rev:	Expected 2018-11-01

Company Profile

Visit company website

Brokerage Center

Compare All Online Brokerages

Market Overview

Tetraphase Pharma TTPH:NASDAQ

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

Membership is Free

What are you waiting for? Sign up now!

Free Account Login

Market Overview

Tickers

Articles

Keywords

Tetraphase Pharma TTPH:NASDAQ

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners